Pre-made Citatuzumab biosimilar ( Fab Fusion, anti-EPCAM therapeutic antibody) - benchmark reference antibody
Cat No.: GMP-Bios-ab-107
Anti-EPCAM therapeutic antibody (Pre-made Citatuzumab biosimilar,Fab Fusion) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Citatuzumab bogatox (VB6-845) is a monoclonal antibody Fab fragment fused with bouganin, a ribosome inactivating protein from the plant Bougainvillea spectabilis. It has undergone preclinical development for the treatment of ovarian cancer and other solid tumors.
Delivery impact due to the Coronavirus Outbreak
With the COVID-19 outbreak in the world, many flights have been cancelled. In order for the customer to receive the goods properly, we use the FedEx Customized Freight (FCF) of Fedex which demands a higher fee. If the delivery fee is more expensive in your area, we will contact you by mail.
|Catalog No.||Package||Price(In USD)||Qty (Quantity)||Sum(In USD)|
|Products Name (INN Index)||Anti-EPCAM therapeutic antibody (Pre-made Citatuzumab biosimilar,Fab Fusion)|
|Highest_Clin_Trial (Jan '20)||Phase-I|
|100% SI Structure||None|
|99% SI Structure||None|
|95-98% SI Structure||None|
|Companies||Viventia Biotech;Sesen Bio|
|Conditions Discontinued||Solid tumours|